Belatacept Conversion in Kidney Transplant: With or without Calcineurin Inhibitor Taper

被引:0
|
作者
Elmasri, A. [1 ]
Valdepenas, B. [1 ]
Benken, S. [1 ]
Hajjiri, Z. [2 ]
Benken, J. [1 ]
机构
[1] Univ Illinois, Chicago, IL USA
[2] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
B202
引用
下载
收藏
页码:S845 / S846
页数:2
相关论文
共 50 条
  • [41] Impact of Belatacept Conversion on Kidney Transplant Function, Histology and Gene Expression
    Sanghi, P.
    Gupta, G.
    Kumar, D.
    Reeve, J.
    Levy, M.
    Sharma, A.
    Fattah, H.
    Kimball, P.
    Massey, H.
    King, A.
    Halloran, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 398 - 398
  • [42] Post Transplant Virologic Outcomes in DCD Kidney Transplant Recipients Treated with Thymoglobulin Induction Immunosuppression and Maintenance Belatacept vs Calcineurin Inhibitor Therapy.
    Engebretsen, T.
    Kueht, M.
    Lea, A.
    Mujtaba, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 935 - 935
  • [43] Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients
    Koppula, Sireesha
    Yost, Sarah E.
    Sussman, Amy
    Bracamonte, Erika R.
    Kaplan, Bruce
    CLINICAL TRANSPLANTATION, 2013, 27 (04) : 591 - 597
  • [44] Conversion to Belatacept in Kidney Transplant Recipients with Systemic Lupus Erythematosus.
    Carrion Barbera, I.
    Fajardo, M. C.
    Tsapepas, D.
    Gartshteyn, J.
    Askanase, A.
    Fernandez, H. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 692 - 693
  • [45] IMPACT OF BELATACEPT CONVERSION ON KIDNEY TRANSPLANT FUNCTION, HISTOLOGY AND GENE EXPRESSION
    Sanghi, P.
    Halloran, P.
    Kumar, D.
    Reeve, J.
    Levy, M.
    Sharma, A.
    Fattah, H.
    Kimball, P.
    Massey, H. D.
    King, A. L.
    Gupta, G.
    NEPHROLOGY, 2017, 22 : 15 - 15
  • [46] CONVERSION FROM CALCINEURIN INHIBITOR-TO BELATACEPT-BASED MAINTENANCE IMMUNOSUPPRESSION IN HEART TRANSPLANT PATIENTS: A SINGLE-CENTER EXPERIENCE
    Fontenay, S.
    Tesmoingt, C.
    Arnaud, P.
    Verdonck, C.
    Dorent, R.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 16 - 16
  • [47] Belatacept for kidney transplant recipients
    Masson, Philip
    Henderson, Lorna
    Chapman, Jeremy R.
    Craig, Jonathan C.
    Webster, Angela C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (11):
  • [48] Conversion to Everolimus in Kidney Transplant Recipients With Calcineurin Inhibitor-Induced Nephropathy: 3 Case Reports
    Nanmoku, Koji
    Shinzato, Takahiro
    Kubo, Taro
    Shimizu, Toshihiro
    Yagisawa, Takashi
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (05) : 1424 - 1427
  • [49] Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy
    Morel, Antoine
    Hoisnard, Lea
    Dudreuilh, Caroline
    Moktefi, Anissa
    Kheav, David
    Pimentel, Ana
    Sakhi, Hamza
    Mokrani, David
    Attias, Philippe
    El Sakhawi, Karim
    Champy, Cecile Maud
    Remy, Philippe
    Sbidian, Emilie
    Grimbert, Philippe
    Matignon, Marie
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [50] Belatacept for kidney transplant recipients
    Webster, Angela
    NEPHROLOGY, 2015, 20 (10) : 752 - 754